No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs3809470 |
chr14:105531945-105531946 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs3809469 |
chr14:105532002-105532003 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs554205408 |
chr14:105532003-105532004 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs147413248 |
chr14:105532014-105532015 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs539702435 |
chr14:105532015-105532016 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs57331203 |
chr14:105532021-105532022 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs187130036 |
chr14:105532023-105532024 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs141174565 |
chr14:105532026-105532027 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs576204774 |
chr14:105532030-105532031 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs111626058 |
chr14:105532031-105532032 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs541576041 |
chr14:105532044-105532045 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs555049811 |
chr14:105532048-105532049 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs571796557 |
chr14:105532052-105532053 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs139153790 |
chr14:105532159-105532160 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs563725953 |
chr14:105532208-105532209 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs540100352 |
chr14:105532238-105532239 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs556900240 |
chr14:105532257-105532258 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs546500177 |
chr14:105532340-105532341 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs562995512 |
chr14:105532370-105532371 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs541274787 |
chr14:105532379-105532380 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs35767183 |
chr14:105532407-105532408 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs368688671 |
chr14:105532412-105532413 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs548791062 |
chr14:105532425-105532426 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs377152604 |
chr14:105532441-105532442 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs191561627 |
chr14:105532456-105532457 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs149923260 |
chr14:105532458-105532459 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs144948124 |
chr14:105532471-105532472 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs148627909 |
chr14:105532473-105532474 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs143210427 |
chr14:105532540-105532541 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs201037938 |
chr14:105532650-105532651 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs556425101 |
chr14:105532651-105532652 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs369039808 |
chr14:105532656-105532657 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs542425128 |
chr14:105532663-105532664 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs535304482 |
chr14:105532777-105532778 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs35858045 |
chr14:105532786-105532787 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs555122983 |
chr14:105532788-105532789 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs181368174 |
chr14:105532789-105532790 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs555718943 |
chr14:105532809-105532810 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs3825765 |
chr14:105532812-105532813 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs533290359 |
chr14:105532835-105532836 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs186282355 |
chr14:105532846-105532847 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs146665759 |
chr14:105532847-105532848 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs563236533 |
chr14:105532857-105532858 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs371558443 |
chr14:105532864-105532865 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs375047578 |
chr14:105532888-105532889 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs542469028 |
chr14:105532919-105532920 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs373438251 |
chr14:105532947-105532948 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs376423979 |
chr14:105533014-105533015 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs562250392 |
chr14:105533083-105533084 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs527852501 |
chr14:105533105-105533106 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|